3658 results for «450»

Filter By

3658 results

TAVI: Challenging clinical scenario

21 Nov 2021 – From PCR London Valves 2021

Learn in this PCR London Valves 2021 session about unusual TAVI cases and the innovative techniques used to treat them: echo-fluoro fusion to guide prosthetic valve leaflet laceration pre-transcatheter AVR, novel advanced augmented reality imaging in high-end transcatheter interventions, transthoracic echo-guided zero-contrast TAVR, and more!

TAVI: Challenging clinical scenario

Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential

22 Nov 2021 – From PCR London Valves 2021

Plunge into the universe of mitral and tricuspid in this PCR London Valves 2021 session, and learn how to optimize patient selection and tailor our procedural strategy, understand how to optimize patient outcomes with dedicated devices, and experience how to maximize the use of the G4...

Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential

...Not just TAVI

21 Nov 2021 – From PCR London Valves 2021

Browse this page to discover simultaneous TAVR and tricuspid valve-in-valve, combined percutaneous valve-in-valve TAVI and mitral repair in degenerated freestyle full root, paravalvular leak post TAVR causing hemolysis treated with balloon dilatation and PVL closure, and much more!

...Not just TAVI

Unfavorable access in TAVI

21 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session will enable you to appreciate an aortic valve-in-valve intervention through right subclavian access, observe a transfemoral TAVI through extremely tortuous aorta, view a challenging case of left axillary access TAVI in bicuspid aortic stenosis, and much more!

Unfavorable access in TAVI

The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes

21 Nov 2021 – From PCR London Valves 2021

In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.

The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes

Challenging routes for TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to look at transfemoral TAVR in patient with severe stenosis of iliac artery, to appreciate a transfemoral aortic valve replacement in a patient affected by abdomen aorta barrage, and more!

Challenging routes for TAVI

Coronaries and TAVI

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos and learn about TAVR in rheumatic patient with aortic regurgitation, IVUS assessment of coronary ostia following transapical ViV TAVI, "Hybrid thinking" off-pump CABG and TAVI for left main disease and CTO with severe aortic stenosis, and more!

Coronaries and TAVI

Best cases session

21 Nov 2021 – From PCR London Valves 2021

This session from the PCR London Valves 2021 Congress compiles a series of the best cases submitted during this edition. Discover, among others, cases of severe aortic valve and ostial coronary disease, as well as transcatheter valvular lithotripsy in cases with severely calcific aortic or mitral...

Best cases session

Stents, scaffolds and DCB

14 Sep 2016

Latest Stents, scaffolds and DCB content in interventional cardiology - research, practice, and education

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools,...

Stents and scaffolds

First report of outcomes in the TRILUMINATE pivotal clinical trial in patients with severe tricuspid regurgitation

21 Sep 2022

Alex Sticchi provides his take on the TRILUMINATE pivotal trial which was presented by David H. Adams at the TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients with Severe Tricuspid Regurgitation

EuroPCR 2024 delivered an eye-opening focus on imaging guidance

24 May 2024

A record 12,100 participants from 130 countries have just taken part in the highly educational WorldLeading Course in interventional cardiovascular medicine. They enjoyed a unique opportunity to exchange their knowledge, skills and experience on a global scale.

Paris – France, 17 May 2024. As always, the thought-provoking...

The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

07 Apr 2024

Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.

Charles Fauvel

Author

Charles Fauvel
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

EuroPCR 2023 – The interventional cardiovascular community is gathering in Paris to learn, share, and shape the future of patient care worldwide

15 May 2023

EuroPCR, the annual world-leading Course in interventional cardiovascular medicine, has been taking place for over 30 years. It is tailored for all those dedicated to the sharing of knowledge and skills, and improvement of patient care worldwide: interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied...

EuroPCR 2023 – The interventional cardiovascular community is gathering in Paris

TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation

04 Mar 2023

Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
Live from ACC.23/WCC: TRILUMINATE pivotal

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase
Jacob Lønborg

Author

Jacob Lønborg
Ali Nazmi Calik

Author

Ali Nazmi Calik
NOTION 3

The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study

03 Nov 2025

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sofia Papadopoulou

Author

Sofia Papadopoulou
INVEST-CTO: Single arm study of a planned investment procedure in high-risk CTO PCI
Didn’t find what you were looking for?